DIVIDEND ANNOUNCEMENT: AbbVie Inc (NYSE:ABBV) on 10/29/2026 declared a dividend of $1.8200 per share

AbbVie Inc (NYSE:ABBV) on 10/29/2026 declared a dividend of $ 1.8200 per share payable on February 16, 2027 to shareholders of record as of January 15, 2027. Dividend amount recorded is an increase of $ 0.09 from last dividend Paid.

AbbVie Inc (NYSE:ABBV) has paid dividends since 2013, has a current dividend yield of 2.3797242641% and has increased its dividends for 12 successive years.

AbbVie Inc's market cap is $ 513,859,952,430 and has a PE ratio of 82.14. The stock price closed yesterday at $ 290.79 and has a 52 week low/high of $ 190.75 and $ 292.67.

AbbVie Inc. is a diversified research-based biopharmaceutical company engaged in the research and development, manufacturing, commercialization and sale of medicines and therapies. It offers a comprehensive product portfolio across Immunology, Oncology, Neuroscience, Eye Care, Aesthetics, and Other Specialties. Immunology includes Rheumatology, Dermatology, and Gastroenterology. Oncology includes Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Diffuse large B-cell lymphoma, and others. Neuroscience includes Parkinson's disease, Migraine, Movement Disorders, Psychiatric Disorders, and Alzheimer's disease.

For more information on AbbVie Inc click here.